SOFIA (Bulgaria), October 7 (SeeNews) -Â Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that its sales revenue increased 2% year-on-year in the first nine months of 2019 on the back of increased sales on the international market.Â